Zobrazeno 1 - 10
of 23
pro vyhledávání: '"A J Munoz Garcia"'
Autor:
M Munoz-Garcia, E Munoz-Garcia, A J Munoz Garcia, A J Dominguez-Franco, M F Jimenez-Navarro, J H Alonso-Briales, J M Hernandez-Garcia, J J Gomez-Doblas
Publikováno v:
European Heart Journal. 43
Background Transcatheter Aortic valve Replacement (TAVR) has emerged as an alternative to surgical aortic valve replacement. It is widely known the short and mid-term outcomes, however, is limited about long-term outcomes in according to age. The 202
Autor:
M Munoz-Garcia, E Munoz-Garcia, A J Munoz Garcia, A J Dominguez-Franco, M F Jimenez-Navarro, J H Alonso-Briales, J M Hernandez-Garcia, J J Gomez-Doblas
Publikováno v:
European Heart Journal. 43
The use of transcatheter aortic valve replacement (TAVR) has expanded as an alternative to surgical aortic valve replacement and has become a widely accepted treatment option for patients with severe aortic stenosis who are considered intermediate- a
Autor:
Erika Muñoz-García, Antonio J. Domínguez-Franco, M F Jimenez-Navarro, J H Alonso-Briales, J M Hernandez-Garcia, Juan José Gómez-Doblas, M Munoz-Garcia, A J Munoz Garcia
Publikováno v:
European Heart Journal. 42
Transcatheter Aortic valve Replacement (TAVR) has emerged as paradigm shift in the treatment of patients with severe symptomatic aortic stenosis. Clinical and performance data on long-term TAVR are still limited. The aim of this study was to determin
Autor:
M Munoz-Garcia, E Munoz-Garcia, A J Munoz Garcia, A J Dominguez-Franco, J H Alonso-Briales, M F Jimenez-Navarro, J M Hernandez-Garcia, J J Gomez-Doblas
Publikováno v:
European Heart Journal. 42
The durability of transcatheter heart valves and long-term clinical outcomes are unknown. The aim of this study was to evaluate clinical and hemodynamic outcomes 10 years after Transcatheter Aortic Valve Implantation (TAVI). Methods Between April 200
Autor:
M Munoz-Garcia, E Munoz-Garcia, A J Munoz Garcia, A J Dominguez-Franco, M F Jimenez-Navarro, J H Alonso-Briales, J M Hernandez-Garcia, J J Gomez-Doblas
Publikováno v:
European Heart Journal. 42
Acute Kidney Injury (AKI) after cardiac surgery is associated with increased mortality, but very few data exist on the occurrence of AKI associated with Transcatheter Aortic Valve Replacement (TAVR). The aim of this study was to determine the frequen
Autor:
Antonio J. Domínguez-Franco, M Munoz-Garcia, Erika Muñoz-García, Juan José Gómez-Doblas, A J Munoz Garcia, J H Alonso-Briales, J M Hernandez-Garcia, M F Jimenez-Navarro
Publikováno v:
European Heart Journal. 42
Transcatheter Aortic Valve Replacement (TAVR) is considered the treatment in patients older or at high or intermediate risk. Results form contemporary randomized trials in low-risk patients will likely broaden the indication of TAVR, but the data reg
Autor:
Antonio J. Domínguez-Franco, M Munoz-Garcia, J M Hernandez-Garcia, Fernando Carrasco-Chinchilla, Erika Muñoz-García, A J Munoz Garcia, Juan José Gómez-Doblas, J H Alonso-Briales, M F Jimenez-Navarro
Publikováno v:
European Heart Journal. 40
Background Many patients undergoing Trancatheter aortic valve replacement (TAVR) for aortic stenosis also have significant mitral regurgitation (MR). We sought to understand the association of concomitant MR with TAVR clinical outcomes, as well chang
Autor:
J H Alonso-Briales, Erika Muñoz-García, A J Munoz Garcia, J M Hernandez-Garcia, M F Jimenez-Navarro, Juan José Gómez-Doblas, M Munoz-Garcia, Antonio J. Domínguez-Franco, Fernando Carrasco-Chinchilla
Publikováno v:
European Heart Journal. 40
The durability of transcatheter heart valves and long-term clinical outcomes are unknown. The aim of this study was to evaluate clinical and hemodynamic outcomes between 5 to 9 years after Transcatheter Aortic Valve Implantation (TAVI). Methods Betwe
Autor:
Juan José Gómez-Doblas, M Munoz-Garcia, Fernando Carrasco-Chinchilla, Antonio J. Domínguez-Franco, A J Munoz Garcia, M F Jimenez-Navarro, Erika Muñoz-García, J M Hernandez-Garcia, J H Alonso-Briales
Publikováno v:
European Heart Journal. 40
Although it is well known, the differences between both sexes in cardiovascular disease, however, there is a lack of data in aortic valve, treated with Transcatheter Aortic Valve Replacement (TAVR). The purpose of our study was to analyze the long-te
Autor:
Erika Muñoz-García, Fernando Carrasco-Chinchilla, J H Alonso-Briales, Juan José Gómez-Doblas, M F Jimenez-Navarro, A J Munoz Garcia, M Munoz-Garcia, Antonio J. Domínguez-Franco, J M Hernandez-Garcia
Publikováno v:
European Heart Journal. 40
Transcatheter Aortic valve Replacement (TAVR) has emerged as an alternative to surgical aortic valve replacement for patients considered at high or prohibitive operative risk. It is widely known the short and mid-term outcomes, however, is limited ab